Cargando…
Efficacy and Safety of Safflower Yellow in Early Diabetic Nephropathy: A Meta-Analysis
BACKGROUND: Diabetic nephropathy (DN) is a major cause of end-stage renal disease. In order to palliate renal function impairment and reduce kidney related mortality, it is crucial to treating DN patients at the early stage. This study aims to assess the efficacy and safety of conventional therapy c...
Autores principales: | Jin, Xiuze, Shi, Liuyan, Chang, Feng, Lu, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393881/ https://www.ncbi.nlm.nih.gov/pubmed/30894876 http://dx.doi.org/10.1155/2019/8065376 |
Ejemplares similares
-
Antioxidant and Anti-Inflammatory Properties of Hydroxyl Safflower Yellow a in Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
por: Fu, Shunlian, et al.
Publicado: (2022) -
Pharmacological Activities of Safflower Yellow and Its Clinical Applications
por: Chen, Yan, et al.
Publicado: (2022) -
Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial
por: Li, Xiao-jin, et al.
Publicado: (2016) -
Therapeutic Efficacy and Safety of Safflower Injection in the Treatment of Acute Coronary Syndrome
por: Lu, Qiang, et al.
Publicado: (2021) -
Safflower yellow pigment and Sanqi Panax notoginseng in the treatment of acute cerebral infarction: a systematic review, meta-analysis, and cost-effectiveness analysis
por: Li, Yang, et al.
Publicado: (2021)